Medicenna Therapeutics announced the appointment of Brent Meadows, MBA, as its Chief Business Officer, CBO, as part of the Company’s plans to establish a world-class C-suite in Boston, the industry’s largest biotech hub. Prior to joining Medicenna, Meadows served as CBO at OncoOne.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MDNA:
- Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management
- Medicenna Therapeutics to host conference call
- Medicenna Therapeutics completes MDNA11 dose escalation
- Medicenna Completes MDNA11 Dose Escalation and Commences Monotherapy Dose Expansion in the Phase 1/2 ABILITY Study
- Medicenna Therapeutics appoints Yavari as Chair of DAC
